Akpash Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2004.
2004 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Akpash Pharmaceuticals Private Limited

Akpash Pharmaceuticals Private Limited, a active private limited company, was established on 27 April 2004 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233MP2004PTC016579. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.40 M and a paid-up capital of ₹2.07 M.

It upholds a compliant status. Employing 6 professional, Its leadership includes Virendra Singh Mandloi (Director), Ashish Joshi (Director), Ajaj Ahmmad (Director). Past directors included Neelam Jadwani, Kamal Keswani, Gopal Das Jadwani. It holds ₹1.95 Cr open charges and ₹8.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 275, Secor-E Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MP2004PTC016579

  • Registration Number

    016579

  • Incorporation Date

    27 April 2004

  • Authorized Capital

    ₹2.40 M

  • Paid-Up Capital

    ₹2.07 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.40 M
  • Paid Up Capital ₹ 2.07 M
  • Company Age 21 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.95 Cr
  • Satisfied Charges ₹ 8.00 M
  • Revenue Growth **** -19.12%
  • Profit Growth **** -12.94%
  • Ebitda **** -24.45%
  • Net Worth -604.17%
  • Total Assets **** 14.02%
Company report

Akpash Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Akpash Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Akpash Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Virendra Singh Mandloi Director 12 Jul 2018 Current
Ashish Joshi Director 19 Dec 2024 Current
Ajaj Ahmmad Director 19 Dec 2024 Current
Ravindra Mandloi Director 12 Jul 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Jul 2018 Past
Pramod Abcsdd Director 21 Dec 2012 Past
Pramod Abcsdd Director 21 Dec 2012 Past
Pramod Abcsdd Director 12 Jul 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Akpash Pharmaceuticals.

Akpash Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 19.12% decrease. The company also saw a substantial fall in profitability, with a 12.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 604.17%.

Akpash Pharmaceuticals revenue growth over time
Akpash Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -19.12%
*******
*******
*******
*******
Revenue from Operations
*******
 -19.40%
*******
*******
*******
*******
Total Assets
*******
 14.02%
*******
*******
*******
*******
Profit or Loss
*******
 -12.94%
*******
*******
*******
*******
Net Worth
*******
 -604.17%
*******
*******
*******
*******
EBITDA
*******
 -24.45%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Akpash Pharmaceuticals?

In 2021, Akpash Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹19,500,000.00

Satisfied Charges

₹8,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 1.15 Cr
  • Allahabad Bank : 0.80 Cr
Latest Charge Details
Date Lender Amount Status
22 Jul 2017 Others ₹1.15 Cr Open
20 Nov 2009 Allahabad Bank ₹8.00 M Open
18 Nov 2005 State Bank Of Indore ₹1.50 M Satisfied
28 Jan 2005 Small Industries Development Bank Of India ₹6.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Akpash Pharmaceuticals?

Akpash Pharmaceuticals has a workforce of 6 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Akpash Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akpash Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Akpash Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Ashish Joshi was appointed as a Director was appointed as a Director on 19 Dec 2024 & has been associated with this company since 1 year 1 month . was completed.

  • Director Appointment

    Ajaj Ahmmad was appointed as a Director was appointed as a Director on 19 Dec 2024 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Annual General Meeting

    Akpash Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Akpash Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.

  • Director Appointment

    The activity Virendra Singh Mandloi was appointed as a Director was appointed as a Director on 12 Jul 2018 & has been associated with this company since 7 years 7 months . was completed.

  • Director Appointment

    Ravindra Mandloi was appointed as a Director was appointed as a Director on 12 Jul 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Akpash Pharmaceuticals Private Limited?

The CIN of Akpash Pharmaceuticals Private Limited is U24233MP2004PTC016579.

Where is Akpash Pharmaceuticals Private Limited headquartered?

Akpash Pharmaceuticals Private Limited is headquartered at 275, Secor-E Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452015.

When was Akpash Pharmaceuticals Private Limited incorporated?

Akpash Pharmaceuticals Private Limited was incorporated on 27 April 2004.

Who are the current directors of Akpash Pharmaceuticals Private Limited?

The current directors of Akpash Pharmaceuticals Private Limited are

What is the primary industry of Akpash Pharmaceuticals Private Limited?

The primary industry of Akpash Pharmaceuticals Private Limited is Manufacturing.

Is Akpash Pharmaceuticals Private Limited a listed company?

Akpash Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Akpash Pharmaceuticals Private Limited?

The authorized capital of Akpash Pharmaceuticals Private Limited is ₹2.40 M, and the paid-up capital is ₹2.07 M.

What is the compliance status of Akpash Pharmaceuticals Private Limited?

The compliance status of Akpash Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available